Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
As an investigational compound it has not completed and at the time of writing has not reported a dedicated cardiovascular-outcomes trial, so there is no evidence yet that it reduces heart attacks or strokes
This work supports and extends our recent study showing that GLP-1 from the OB also controls the odour-evoked cephalic phase of insulin secretion 16
Clinical outcomes depend on dose optimization and patient adherence rather than brand statusboth of which PlexusDx supports through transparent pricing and personalized genetic guidance
2008 Nov;42(11):1686-91
Immune Modulation: The peptide's effects on inflammatory pathways suggest caution for: Active autoimmune conditions Immunocompromised individuals Those taking immunomodulatory medications Populations Requiring Extra Caution Avoid or Use Extreme Caution: Active cancer or history of cancer Pregnancy or breastfeeding Children and adolescents Severe cardiovascular disease Active infections Immediately pre or post-surgery (without medical guidance) Drug Interactions Theoretical Interactions Given BPC-157's mechanisms, theoretical interactions exist with: Medications Affecting NO System: Nitrates (nitroglycerin, isosorbide) PDE5 inhibitors (sildenafil, tadalafil) Some blood pressure medications Reasoning: Combined NO system effects Anticoagulants and Antiplatelets: Warfarin Aspirin Clopidogrel Direct oral anticoagulants Reasoning: Angiogenic effects may affect bleeding Growth Hormone and Related: HGH IGF-1 Other growth-promoting compounds Reasoning: Additive growth factor effects Immunomodulators: Corticosteroids TNF-alpha inhibitors Other immunosuppressants Reasoning: Overlapping immune effects NSAIDs A Special Case Interestingly, while drug interactions are generally concerning, research suggests BPC-157 may protect against NSAID damage
[160] Profits from Novo Nordisk result in increased Danish tax revenues and employment
US$ 23.43
US$ 27.01
US$ 20.88
